These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
358 related items for PubMed ID: 10782817
1. Antiprothrombin and antiannexin V antibodies imply risk of thrombosis in patients with systemic autoimmune diseases. Lakos G, Kiss E, Regeczy N, Tarjan P, Soltesz P, Zeher M, Bodolay E, Szucs G, Szakony S, Sipka S, Szegedi G. J Rheumatol; 2000 Apr; 27(4):924-9. PubMed ID: 10782817 [Abstract] [Full Text] [Related]
2. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus. Bertolaccini ML, Atsumi T, Escudero Contreras A, Khamashta MA, Hughes GR. J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209 [Abstract] [Full Text] [Related]
3. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus. Szodoray P, Tarr T, Tumpek J, Kappelmayer J, Lakos G, Poor G, Szegedi G, Kiss E. Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489 [Abstract] [Full Text] [Related]
5. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review. Bruce IN, Clark-Soloninka CA, Spitzer KA, Gladman DD, Urowitz MB, Laskin CA. J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672 [Abstract] [Full Text] [Related]
6. [Antiphospholipid antibodies: clinical significance and biological diagnosis]. Arnoux D, Boutière B, Sanmarco M. Ann Biol Clin (Paris); 2000 Dec; 58(5):557-74. PubMed ID: 11022099 [Abstract] [Full Text] [Related]
7. Clinical significance of antiphospholipid protein antibodies. Receiver operating characteristics plot analysis. Musial J, Swadzba J, Motyl A, Iwaniec T. J Rheumatol; 2003 Apr; 30(4):723-30. PubMed ID: 12672190 [Abstract] [Full Text] [Related]
8. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests. Day HM, Thiagarajan P, Ahn C, Reveille JD, Tinker KF, Arnett FC. J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167 [Abstract] [Full Text] [Related]
14. Prevalence and clinical significance of antiprothrombin antibodies in patients with systemic lupus erythematosus or with primary antiphospholipid syndrome. Muñoz-Rodríguez FJ, Reverter JC, Font J, Tàssies D, Cervera R, Espinosa G, Carmona F, Balasch J, Ordinas A, Ingelmo M. Haematologica; 2000 Jun; 85(6):632-7. PubMed ID: 10870121 [Abstract] [Full Text] [Related]
17. High prevalence of anti-prothrombin antibody in patients with deep vein thrombosis. Ishikura K, Wada H, Kamikura Y, Hattori K, Fukuzawa T, Yamada N, Nakamura M, Nobori T, Nakano T. Am J Hematol; 2004 Aug; 76(4):338-42. PubMed ID: 15282665 [Abstract] [Full Text] [Related]
18. Anti-beta2-glycoprotein I autoantibodies, in vitro thrombin generation, and the antiphospholipid syndrome. Hanly JG, Smith SA. J Rheumatol; 2000 Sep; 27(9):2152-9. PubMed ID: 10990227 [Abstract] [Full Text] [Related]
19. Antibodies to beta2-glycoprotein I: a potential marker for clinical features of antiphospholipid antibody syndrome in patients with systemic lupus erythematosus. Sanfilippo SS, Khamashta MA, Atsumi T, Amengual O, Bertolaccini ML, D'Cruz D, Amft N, Swana GT, Hughes GR. J Rheumatol; 1998 Nov; 25(11):2131-4. PubMed ID: 9818654 [Abstract] [Full Text] [Related]